Callan Family Office’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.32M Sell
39,718
-1,078
-3% -$81.2K 0.08% 254
2025
Q4
$2.73M Buy
40,796
+21,859
+115% +$1.41M 0.06% 285
2025
Q3
$1.28M Sell
18,937
-1,501
-7% -$109K 0.04% 337
2025
Q2
$1.52M Buy
20,438
+14,102
+223% +$939K 0.05% 308
2025
Q1
$399K Sell
6,336
-5,401
-46% -$334K 0.03% 374
2024
Q4
$669K Buy
+11,737
New +$694K 0.04% 317

Other funds holding CTVA

Callan Family Office's CTVA Position: Q1 2026 in Review

Callan Family Office reduced its Corteva (CTVA) stake by 2.6% in Q1 2026, selling an estimated $81.2K and leaving 39,718 shares worth $3.32M. The position accounts for 0.08% of the portfolio, ranked #254.

Callan Family Office first reported a position in CTVA in Q4 2024 and has held it in 6 quarters since. 1,476 funds tracked by Wall St. Rank hold CTVA as of Q1 2026.

  • Callan Family Office held 39,718 shares of Corteva worth $3.32M as of Q1 2026.
  • Callan Family Office sold 1,078 Corteva shares in Q1 2026, an estimated $81.2K.
  • Corteva made up 0.08% of Callan Family Office's portfolio in Q1 2026, its #254 holding.
  • Callan Family Office first reported a position in Corteva in Q4 2024 and has held it in 6 quarters since.
  • 1,476 funds tracked by Wall St. Rank held Corteva as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.